Screener
PTC Therapeutics PTCT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net product revenue | $225,573 | $153,426 |
| Collaboration and license revenue | 143 | 986,231 |
| Royalty revenue | 46,835 | 36,439 |
| Total revenues | 272,551 | 1,176,096 |
| Operating expenses: | ||
| Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets | 28,028 | 12,862 |
| Amortization of acquired intangible assets | 11,581 | 3,798 |
| Research and development | 100,873 | 108,973 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's total revenue?
- PTC Therapeutics (PTCT) reported total revenue of $272.55M in Q1 2026.
- How has PTC Therapeutics's total revenue changed year-over-year?
- PTC Therapeutics's total revenue decreased by 76.8% year-over-year, from $1.18B to $272.55M.
- What is the long-term trend for PTC Therapeutics's total revenue?
- Over 4 years (2021 to 2025), PTC Therapeutics's total revenue has grown at a 33.9% compound annual growth rate (CAGR), from $538.59M to $1.73B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about PTC Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude